Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: J Neurochem. 2013 Jun 27;127(5):691–700. doi: 10.1111/jnc.12334

Figure 2.

Figure 2

Levels of the microglial marker, CD68, are increased in the brains of LMA eNOS−/− mice. (A) Fixed tissue sections from the brains of LMA eNOS−/− and LMA wild type mice were immunolabeled with anti-CD68. Representative images of the cortex are shown. Magnification 40x; bar is representative of 20μm. (B) Brain tissue from LMA eNOS−/− and LMA wild type animals was Western blotted using anti-CD68, anti-GFAP, anti-NeuN, and anti-Actin (loading control) antibodies. Representative image is shown. Densitometric analysis was performed for (C) CD68, (D) GFAP, and (E) NeuN. Data are presented as mean ±SD (*P<0.05 compared to wild type control mice, n=10–12 animals).